ATNF insider transaction filings
180 Life Sciences Corp. — 31 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-08-12. Screen ATNF transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-08-12 | 4 | Rudisill McAndrew — Director | Grant/award (A): 957,002 (derivative) @ $0 | EDGAR |
| 2025-08-11 | 4 | Shoemaker Stephen H — Director | Grant/award (A): 181,422 (derivative) @ $0 | EDGAR |
| 2025-08-11 | 4 | Jordan Blair — Chief Executive Officer, Director | Grant/award (A): 771,044 (derivative) @ $0 | EDGAR |
| 2025-08-11 | 4 | Smith Ryan Lewis — Director | Grant/award (A): 771,044 (derivative) @ $0 | EDGAR |
| 2025-08-07 | 4 | Shoemaker Stephen H — Director | Grant/award (A): 919,761 (derivative) @ $0 | EDGAR |
| 2025-08-06 | 4 | Jordan Blair — Chief Executive Officer, Director, 10% owner | Grant/award (A): 3,908,986 (derivative) @ $0 | EDGAR |
| 2025-08-06 | 4 | Smith Ryan Lewis — Director | Grant/award (A): 3,908,986 (derivative) @ $0 | EDGAR |
| 2025-07-14 | 4 | Shoemaker Stephen H — Director | Holdings only — no transactions reported | EDGAR |
| 2025-07-14 | 4 | Van Lent Eric R — Chief Accounting Officer | Holdings only — no transactions reported | EDGAR |
| 2025-07-14 | 4 | Jordan Blair — Chief Executive Officer, Director, 10% owner | Other (J): 160,000 · Other (J): 160,000 | EDGAR |
| 2025-07-14 | 4 | Smith Ryan Lewis — Director | Holdings only — no transactions reported | EDGAR |
| 2025-07-14 | 4 | STEINMAN LAWRENCE — Director | Holdings only — no transactions reported | EDGAR |
| 2025-06-30 | 4/A | Shoemaker Stephen H — Director | Grant/award (A): 67,439 @ $0 · Grant/award (A): 165,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4/A | Jordan Blair — Chief Executive Officer, Director, 10% owner | Grant/award (A): 167,576 @ $0 · Grant/award (A): 410,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4/A | Van Lent Eric R — Chief Accounting Officer | Grant/award (A): 8,174 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4/A | Smith Ryan Lewis — Director | Grant/award (A): 102,181 @ $0 · Grant/award (A): 255,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4/A | STEINMAN LAWRENCE — Director | Grant/award (A): 44,959 @ $0 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Shoemaker Stephen H — Director | Grant/award (A): 72,297 @ $0 · Grant/award (A): 165,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Jordan Blair — Chief Executive Officer, Director, 10% owner | Grant/award (A): 179,646 @ $0 · Grant/award (A): 410,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Van Lent Eric R — Chief Accounting Officer | Grant/award (A): 8,763 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Smith Ryan Lewis — Director | Grant/award (A): 109,541 @ $0 · Grant/award (A): 255,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | STEINMAN LAWRENCE — Director | Grant/award (A): 48,198 @ $0 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2025-04-30 | 4 | Jordan Blair — Chief Executive Officer, Director, 10% owner | Other (J): 1,318,000 @ $0 | EDGAR |
| 2025-04-11 | 4 | ELRAY RESOURCES, INC. — 10% owner | Conversion (C): 1,318,000 · Conversion (C): 1,000,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Jordan Blair — Chief Executive Officer, Director | Other (J): 200,000 @ $0 | EDGAR |
| 2025-02-24 | 4 | Shoemaker Stephen H — Director | Grant/award (A): 65,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | Goodman Jay Lawrence — Director | Grant/award (A): 65,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | Jordan Blair — Chief Executive Officer, Director | Grant/award (A): 160,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | Smith Ryan Lewis — Director | Grant/award (A): 65,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | STEINMAN LAWRENCE — Director | Grant/award (A): 65,000 @ $0 | EDGAR |
| 2025-02-07 | 4 | Jordan Blair — Chief Executive Officer, Director | Other (J): 43,166 @ $0 | EDGAR |
Recent 8-K events — 180 Life Sciences Corp.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-19 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-16 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-30 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-29 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-17 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ATNF returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →